LYKA LABS
Back to Balance Sheet
|
LYKA LABS Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹4.29 Cr | ₹3.83 Cr | ₹4.01 Cr | ₹4.23 Cr | ₹-16 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of LYKA LABS ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹4.29 Cr |
| Mar2024 | ₹3.83 Cr |
| Mar2023 | ₹4.01 Cr |
| Mar2022 | ₹4.23 Cr |
| Mar2021 | ₹-16 Cr |
How is Deferred Tax Assets / Liabilities of LYKA LABS Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹4.29 Cr | 12.15 | |
| Mar2024 | ₹3.83 Cr | -4.54 | |
| Mar2023 | ₹4.01 Cr | -5.27 | |
| Mar2022 | ₹4.23 Cr | Positive | |
| Mar2021 | ₹-16 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of LYKA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LYKA LABS | ₹252.8 Cr | -3% | -11.9% | -49.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,615.0 Cr | 4% | -4.9% | -2.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,943.0 Cr | 1.1% | -9.3% | 9.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹133,336.0 Cr | -1.3% | -3.7% | 24% | Stock Analytics | |
| CIPLA | ₹107,499.0 Cr | 1.5% | -9.3% | -7.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,590.0 Cr | 5% | -0.1% | 3.3% | Stock Analytics | |
LYKA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LYKA LABS | -3% |
-11.9% |
-49.8% |
| SENSEX | 3.5% |
-1.7% |
7.8% |
You may also like the below Video Courses